Patients with certain genetic profiles may be predisposed to stronger initial side effects or faster adaptation
Healthy Diet Adopting a healthy diet is essential for anyone looking to maximize the benefits of GLP-1 medications and manage diabetes effectively
SELECT Trial Semaglutide 2.4 mg Cuts CV Events 20% (NEJM 2023) STEP 1 Trial Semaglutide 2.4 mg Weight Loss: 68 Weeks (NEJM 2021) High Prevalence of Metabolic Obesity in India: ICMR-INDIAB-23 STEP UP Trial: Semaglutide 7.2mg Achieves 20.7% Mean Weight Loss Over 72 Weeks ESI Clinical Practice Guidelines for the Evaluation and Management of Obesity in India GLP-1 Receptor Agonists: Cardiovascular, Mortality, and Kidney Outcomes Systematic Review and Meta-Analysis (Lancet 2021) Brand guide DCGI-approved generics from Sun Pharma, Dr
A: Yes, Zepbound and Tirzepatide are commonly used for weight loss and are generally well-tolerated when prescribed and monitored by a healthcare professional, as shown in clinical trials
Sublingual NAD + for absorption into circulation is another new commercially proposed method
Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products
